Colon Adenocarcinoma

我们是谁

  • December 8, 2022
    Evaluating Novel Therapies in ctDNA Positive GI Cancers
  • 2022 年 4 月 5 日
    S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
  • 2022 年 4 月 5 日
    Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer